Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/5/2022
Recent Executive Moves
8/5/2022
Bird's Eye View of Chinese Pharma Now: A Mixed Bag of Mostly Negative ...
8/2/2022
China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...
7/29/2022
Drug R&D and Approvals in China – June Update on YouTube (PharmCube)
7/29/2022
Pricing and Market Access in China: How Medtechs Can Succeed
7/29/2022
CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines ICH ...
7/29/2022
NHC and SATCM Issues Notice to Further Strengthen Drug Safety Manageme...
7/29/2022
Recent Official and Executive Moves
7/29/2022
Financial-related Company News in Brief (July 2022)
7/28/2022
Cosmo and 3SBio Enter License Agreement for Winlevi in Greater China
7/28/2022
June In-Licensing Deals in China Biotech Drop to A New Low (PharmaDJ)
7/26/2022
Biotech fundraising in China Warms Up A Little in June (PharmaDJ)
7/26/2022
Mobile Health Applications for Depression in China: A Systematic Revie...
7/26/2022
NHSA and MOF Issues Notice to Further Implement BMI Inter-provincial M...
7/26/2022
MSD and Kelun Enter Oncology Research Collaboration and License Agre...
7/26/2022
Review of Chinese Hospital Drug Market in Q1/2022
7/22/2022
AbbVie Terminates Early-stage Study of I-Mab's Antibody lemzoparlimab...
7/22/2022
Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...
7/22/2022
Novaremed Enters License Pact with NeuroFront for Non-opioid Neuropath...
7/21/2022
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...
7/21/2022
A Practical Review of the New Supporting Regulations of China's Anti-M...
7/21/2022
A Practical Review of the Amended Anti-Monopoly Law of China: Highligh...
7/21/2022
Draft "Regulation on Prohibition for Abuse of IP Rights to Exclude or ...
7/20/2022
China's Prospective Payment System: 3 Ways to Prepare
7/20/2022
Official Data: Chinese Pharma Growth Slows in H1/2022
7/19/2022
WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
7/19/2022
WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...
7/19/2022
CDE Solicits Comments on the Draft Guidelines for Clinical Development...
7/19/2022
NHSA Issues New Notice to Further Strengthen Regulation of Medical Ser...
7/18/2022
Pharmanovia Expands Its Footprint in China With The Acquisition of Roc...
Page:
40
/
333
Total number of articles:
9989
:
[First]
[<<]
[38]
[39]
[40]
[41]
[42]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit